Cara Therapeutics Announces Positive Results From Phase 2 Trial in Uremic Pruritus
Go back to Cara Therapeutics Announces Positive Results From Phase 2 Trial in Uremic Pruritus| CARA THERAPEUTICS (NASDAQ: CARA) | Delayed: 5.32 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.32 | 52 Week High | $17.69 | |||
| Open | $693.23 | 52 Week Low | $4.26 | |||
| Day High | $5.32 | P/E | N/A | |||
| Day Low | $5.32 | EPS | $-0.42 | |||
| Volume | 0 | |||||
